Pages
- Home
- Library technologies
- Partnering, Collaboration & Pipeline
- Antibody Discovery
- Company
- Project design & Licensing
- Bioinformatics / YUcare
- Contract Research
- Antibody Engineering
- Antibody Humanization
- Events
- News
- Legal notice
- Disclaimer
- Terms and conditions
- Sitemap
- Directions
- New Technologies
Posts by category
- Category: Allgemein
- Category: Events Archive
- Deutsche Biotechnologie Tage – April 09.-10. 2019
- BIO International Conference – March 05.-06. 2019
- BIO Asia International Conference – March 05.-06. 2019
- 9th Alpbach Workshop on Affinity Proteomics – March 11.-13. 2019
- PEGS virtual – June 02-26, 2020
- BIO Digital – June 08-12, 2020
- BIO-EUROPE SPRING digital – March 22-25, 2021
- PEGS BOSTON VIRTUAL – May 11-14, 2021
- Category: Homepage Teaser
- Category: News
- First hospitalized COVID-19 patient treated with COR-101 antibody
- Human SARS-CoV-2 antibody COR-101 shows high efficacy in animal model
- Mechanism of action for human SARS-CoV-2 antibody COR-101 identified
- Innovation Award for CORAT’s COVID-19 antibody development
- COVID-19: Media coverage of YUMAB’s activities
- CORAT’s human COVID-19 antibody ready for clinical trials
- Category: News Archive
- YUMAB announces new research & collaboration agreement with Merck
- CORAT Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program
- COVID-19: First SARS-CoV-2 neutralizing antibody discovered
- COVID-19: Lower Saxony’s health minister visits YUMAB
- YUMAB partner Enleofen enters joint development with Boehringer Ingelheim
- YUMAB statement regarding the coronavirus crisis
- COVID-19: Media coverage of YUMAB’s activities – Archive
YUMAB GmbH
Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany
Phone: +49 531 481170-0
Fax: +49-531 481170-17